Treatment for hypertension, female in Europe & Central Asia
Europe & Central Asia: Treatment for hypertension, female was 58.6% in 2019. ▲ Rising
Treatment for hypertension, female in Europe & Central Asia, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of female adults ages 30-79 with hypertension.
Analysis
In 2019, treatment for hypertension, female in Europe & Central Asia stood at 58.6%.
That represents a change of down 0.3% on the previous year and up 1.4% over ten years.
Over the whole period, treatment for hypertension, female in Europe & Central Asia peaked at 59.2% in 2014 and was at its lowest, 32.5%, in 1990.
Europe & Central Asia ranks 13th of 43 groups on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, female in Europe & Central Asia, year by year
| Year | % of female adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 32.5% | — |
| 1991 | 33.7% | +3.8% |
| 1992 | 35.0% | +3.8% |
| 1993 | 36.3% | +3.8% |
| 1994 | 37.7% | +3.8% |
| 1995 | 39.2% | +3.8% |
| 1996 | 40.7% | +3.8% |
| 1997 | 42.2% | +3.6% |
| 1998 | 43.7% | +3.6% |
| 1999 | 45.1% | +3.4% |
| 2000 | 46.6% | +3.3% |
| 2001 | 48.1% | +3.2% |
| 2002 | 49.6% | +3.1% |
| 2003 | 51.1% | +3.0% |
| 2004 | 52.5% | +2.8% |
| 2005 | 53.9% | +2.6% |
| 2006 | 55.1% | +2.3% |
| 2007 | 56.2% | +1.9% |
| 2008 | 57.0% | +1.6% |
| 2009 | 57.7% | +1.2% |
| 2010 | 58.3% | +1.0% |
| 2011 | 58.7% | +0.7% |
| 2012 | 59.0% | +0.5% |
| 2013 | 59.2% | +0.3% |
| 2014 | 59.2% | +0.1% |
| 2015 | 59.2% | -0.1% |
| 2016 | 59.1% | -0.1% |
| 2017 | 58.9% | -0.3% |
| 2018 | 58.7% | -0.3% |
| 2019 | 58.6% | -0.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 38.6% | 32.5% | 45.1% | 10 |
| 2000s | 52.8% | 46.6% | 57.7% | 10 |
| 2010s | 58.9% | 58.3% | 59.2% | 10 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0351 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 0.3995 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per capita 0.0355 units per person (2025)
Frequently asked questions
- What is treatment for hypertension, female in Europe & Central Asia?
- Treatment for hypertension, female in Europe & Central Asia was 58.6% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, female recorded in Europe & Central Asia?
- The highest recorded value was 59.2% in 2014.
- What is the lowest treatment for hypertension, female recorded in Europe & Central Asia?
- The lowest recorded value was 32.5% in 1990.
- How does Europe & Central Asia rank for treatment for hypertension, female?
- Europe & Central Asia ranks 13th out of 43 groups with data for 2019.
- Is treatment for hypertension, female rising or falling in Europe & Central Asia?
- Over the last ten years it is up 1.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.